Peng Xu

Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer

Daniel V.T. Catenacci, Melissa R. Junttila, Theodore Karrison et al. · Journal of Clinical Oncology · 2015 · 524 citations

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Gabrielle S. Wong, Jin Zhou, Jie Bin Liu et al. · Nature Medicine · 2018 · 268 citations · Full text

Tumor Biology, Oncology, Esophageal Cancer +9

The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo

Peng Xu, Mingzhe Qiu, Zhiyong Zhang et al. · Journal of Neuro-Oncology · 2009 · 72 citations

Neuro-oncology, Ependyma, Glioma +9

Downregulated TRPV1 Expression Contributes to Melanoma Growth via the Calcineurin-ATF3-p53 Pathway

Yuqi Yang, Weinan Guo, Jingjing Ma et al. · Journal of Investigative Dermatology · 2018 · 60 citations

Cancer Research, Trpv1 Expression Contributes, Medicine +10

Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-κB/IKK Pathway-Induced Apoptosis

Yong Wang, He Wang, Wei Zhang et al. · PLoS ONE · 2013 · 49 citations · Full text

Chemoprevention Strategy, Apoptosis, Cell Death +16